Alpha-Synuclein Detection Assay Using Fluorophore-Bound Beads
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current techniques, such as real-time quaking induced conversion (RT-QuIC), have failed to reliably detect alpha-synuclein aggregates in biological samples, which are indicative of neurodegenerative disorders like Parkinson's disease and Dementia with Lewy bodies.
Innovation Solution
A modified RT-QuIC method involving a reaction sample with beads, a fluorophore that binds to protein aggregates, and alpha-synuclein or its fragments, which is used to detect alpha-synuclein aggregates in biological samples by measuring fluorescence changes during incubation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If ELISA is used to measure alpha-synuclein concentrations in CSF, then a biomarker for alpha-synuclein related disorders can be obtained, but the results are inconsistent and show considerable overlap between patient and control groups
Solution Approach 1:
The invention segments the detection process by first isolating alpha-synuclein aggregates from monomeric forms using size-exclusion chromatography or ultracentrifugation, then separately detecting the aggregated fraction. This segmentation allows specific detection of pathogenic aggregates while excluding monomeric alpha-synuclein that causes background noise in conventional ELISA assays, thereby improving both precision and reliability
Solution Approach 2:
The invention introduces intermediary reagents including aggregate-specific antibodies (such as anti-pSyn antibodies that recognize phosphorylated epitopes), conformation-specific antibodies, or seed amplification reagents that selectively bind to or amplify aggregated alpha-synuclein. These intermediaries enable specific detection of the aggregated form while ignoring monomeric forms, resolving the inconsistency problem in conventional assays
2Adaptability or versatility
If RT-QuIC technique is used to detect alpha-synuclein aggregation, then the ability to detect self-aggregation can be exploited, but the technique has failed to reliably detect the presence of alpha-syn or alpha-syn aggregation in biological samples
Solution Approach 1:
The invention applies local quality by creating heterogeneous reaction conditions within the assay system, including using a combination of different bead types (e.g., magnetic beads for separation and non-magnetic beads for aggregation), varying local concentrations of alpha-synuclein seeds, and creating microenvironments with optimal pH and ionic strength. This local optimization enables reliable detection while maintaining the self-aggregation detection capability
Solution Approach 2:
The invention uses composite materials including magnetic beads coated with specific antibodies, fluorophore-conjugated proteins, and combination reagent systems that integrate multiple detection mechanisms. These composite materials enhance the reliability of RT-QuIC by providing both magnetic separation capability and fluorescence detection, while maintaining the ability to detect self-aggregation of alpha-synuclein
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high sensitivity and specificity in detecting alpha-synuclein aggregates, allowing for the differentiation of alpha-synucleinopathy-related pathologies from other protein aggregate-related pathologies.
Implementation Method 1
a fluorophore adapted to bind to protein aggregates and to increase fluorescence when bound to protein aggregates
Data Source
AI summary
A method of detecting the presence of alpha-synuclein aggregation in a biological sample is provided whereby a biological sample is mixed with a reaction sample comprising a population of beads, a fluorophore adapted to bind to protein aggregates and to increase fluorescence when bound to protein aggregates, and alpha-synuclein or a fragment or variant thereof to form a reaction mixture, wherein a significant increase in the fluorescence of the reaction mixture during incubation is indicative of the presence of aggregates of alpha-synuclein in the biological sample.